The following market research report is for the ever-changing, ever-evolving In Vitro Diagnostics (IVD) market in China. The current report is the most updated report you will find on the China In Vitro Diagnostics (IVD) market. Using 2020 and preceding years as the base, the report carries accurate data on the forecasts from the year 2020 to 2025. From current statistics, facts and figures of the industry to the future prospects, business strategies and revenue of the biggest operators in the industry, you will find all the data that’s been thoroughly cross-checked and verified by the finest authors and researchers. Keyplayers and more - all the biggest companies operating in the China In Vitro Diagnostics (IVD) market have been profiled and analyzed in the report as well.
China in vitro diagnostics(IVD) market is anticipated to grow over US$ 11 Billion by 2025 with an impressive double-digit growth rate in the forecast period 2018 - 2025.
The market is driven by number of factors such as rising incidences of chronic lifestyle diseases, public health awareness, demand of tests in rural areas stimulated by the healthcare reform plan, increasing demand from the middle class for high–end products and an increase in the number of private hospitals and independent testing laboratories.
“China In Vitro Diagnostics (IVD) Market Analysis 2012 – 2017 and Forecast 2018 - 2025: Clinical Chemistry,Immunoassay,Molecular Testing,SMBG,Point of Care Testing (POCT), Hematology,Coagulation,Microbiology,Genetic Testing,Infectious Diagnostics,Histology and Cytology” presents an in-depth assessment of the in vitro diagnostics(IVD) market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for in vitro diagnostics(IVD) in China. The research includes historic data from 2012 to 2017 and forecasts until 2025.
The report contains a granular analysis of the China in vitro diagnostics market segmentation by 11 applications and illustrative forecast to 2025.A comprehensive analysis has been done on market share of China in vitro diagnostics by application, end-user and company share by revenue.
The report also includes assessment of in vitro diagnostics regulation in China.Key trends in terms of partnerships and recent developments are analyzed with details. The report also explores detailed description of growth drivers,restraints, trends and opportunities of the China in vitro diagnostics market.
Market Segmentation by Application and Analysis (2012 - 2025)
• Clinical Chemistry
• Immunoassay
• Molecular Testing
• Self–Monitoring of Blood Glucose (SMBG)
• Point of Care Testing (POCT)
• Hematology
• Coagulation
• Microbiology
• Genetic Testing
• Infectious Diagnostics
• Histology and Cytology
The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:
• Roche Diagnostics
• Abbott Laboratories
• Siemens Healthineers
• Sysmex Corporation
• Mindray Medical International Limited
• Beckman Coulter Inc
• Shanghai Fosun Pharmaceutical Group
• Thermo Fisher Scientific Inc
• Hologic Inc
• Qiagen
• Cepheid
• Bio-Rad Laboratories Inc
• Da An Gene Co. Ltd
• Shanghai Kehua Bio–Engineering Co. Ltd.
The Latest Industry Data Included in this Report:
• China In Vitro Diagnostics Market Revenue & Forecast (2012 – 2025)
• China In Vitro Diagnostics Market Dynamics
• China In Vitro Diagnostics Market Segmentation by Application (2012 – 2025)
• China In Vitro Diagnostics Market Revenue Share by Application (2012 – 2025)
• China In Vitro Diagnostics Market, Company Share by Revenue, 2017
• China In Vitro Diagnostics Market Share by End-User (Hospitals, Homecare, Research Institutes, Independent laboratories),2017
• Assessmentof In Vitro Diagnostics Regulation in China
• Major Partnership Deals in China In Vitro Diagnostics Market
• Recent Developments in China In Vitro Diagnostics Market
• Overview of Key Companies in China In Vitro Diagnostics Market
The report contains qualitative analysis, quantitative analysis and even regional analysis of major markets to cover all aspects of the China In Vitro Diagnostics (IVD) market. You can use this report for investments or business strategies. Get in touch with Market Research Port today for the best price on the China In Vitro Diagnostics (IVD) market research report.
Table of Contents
1. Executive Summary
2. China In Vitro Diagnostics Market Revenue & Forecast (2012 – 2025)
3. China In Vitro Diagnostics Market Revenue Share by Application (2012 – 2025)
4. China In Vitro Diagnostics Market, Company Share by Revenue, 2017
5. China In Vitro Diagnostics Market Dynamics
5.1 Drivers
5.2 Restraints
5.3 Trends & Opportunities
6. China In Vitro Diagnostics Market Segmentation by Application (2012 – 2025)
6.1 Clinical Chemistry
6.2 Immunoassay
6.3 Molecular Testing
6.4 Self–Monitoring of Blood Glucose (SMBG)
6.5 Point of Care Testing (POCT)
6.6 Hematology
6.7 Coagulation
6.8 Microbiology
6.9 Genetic Testing
6.10 Infectious Diagnostics
6.11 Histology and Cytology
7. China In Vitro Diagnostics Market Share by End-User (Hospitals, Homecare, Research Institutes, Independent laboratories),2017
8. Assessment of In Vitro Diagnostics Regulation in China
9. Major Partnership Deals in China In Vitro Diagnostics Market
10. Recent Developments in China In Vitro Diagnostics Market
11. Overview of Key Companies in China In Vitro Diagnostics Market
11.1 Roche Diagnostics
11.1.1 Company Overview
11.2 Abbott Laboratories
11.2.1 Company Overview
11.3 Siemens Healthineers
11.3.1 Company Overview
11.4 Sysmex Corporation
11.4.1 Company Overview
11.5 Mindray Medical International Limited
11.5.1 Company Overview
11.6 Beckman Coulter Inc
11.6.1 Company Overview
11.7 Shanghai Fosun Pharmaceutical Group
11.7.1 Company Overview
11.8 Thermo Fisher Scientific Inc
11.8.1 Company Overview
11.9 Hologic Inc
11.9.1 Company Overview
11.10 Qiagen
11.10.1 Company Overview
11.11 Cepheid
11.11.1 Company Overview
11.12 Bio-Rad Laboratories Inc
11.12.1 Company Overview
11.13 Da An Gene Co. Ltd
11.13.1 Company Overview
11.14 Shanghai Kehua Bio–Engineering Co. Ltd.
11.14.1 Company Overview
